Search results for "Renal cell carcinoma"

showing 10 items of 164 documents

Oncologic Long-term Outcome of Elective Nephron-sparing Surgery Versus Radical Nephrectomy in Patients With Renal Cell Carcinoma Stage pT1b or Greate…

2011

Objectives To analyze the oncologic outcome and overall survival (OS) for patients with renal cell carcinoma (RCC) >4 cm undergoing radical nephrectomy (RN) or elective nephron-sparing surgery (NSS) in a matched-pair cohort. Methods From 1988 to 2007, we identified 829 patients in our clinic treated with either RN (n = 641) or open NSS (n = 188) for renal masses >4 cm. After matching the cohort for age, time of surgery, grade, TNM stage, tumor size, and sex and excluding patients with metastases, benign lesions with an imperative indication, and those with missing records, 173 remained for oncologic analysis. OS, cancer-specific survival, and progression-free survival were estimated using t…

AdultMalemedicine.medical_specialtyMatched-Pair AnalysisUrologymedicine.medical_treatmentNephrectomyRenal cell carcinomaHumansMedicineIn patientStage (cooking)Carcinoma Renal CellAgedProportional Hazards ModelsAged 80 and overbusiness.industryProportional hazards modelHazard ratioMiddle Agedmedicine.diseaseKidney NeoplasmsConfidence intervalNephrectomySurgeryTreatment OutcomeElective Surgical ProceduresCohortDisease ProgressionFemalebusinessUrology
researchProduct

Nephron-sparing surgery of renal cell carcinoma with a normal opposite kidney: long-term outcome in 180 patients

2000

Abstract Objectives. To investigate the long-term outcome of an organ-saving approach for renal cell carcinoma (RCC) with a normal opposite kidney (elective indication). Methods. Since 1979, 180 patients have undergone nephron-sparing surgery at our institution for RCC in the presence of a normal contralateral kidney. The mean age was 56 years (range 23 to 83), and the mean follow-up was 4.7 years (maximum 14.8). Most of these tumors were found incidentally, with a mean tumor diameter on ultrasound of 3.3 cm (range 1.0 to 8.6). Results. The postoperative course was unremarkable in 173 patients. Postoperative bleeding was encountered in 4 patients and urinary extravasation in an additional 3…

AdultMalemedicine.medical_specialtyUrologyNephronNephrectomyPostoperative ComplicationsRenal cell carcinomaCarcinomaHumansMedicineCarcinoma Renal CellSurvival rateAgedAged 80 and overKidneybusiness.industryUltrasoundMiddle Agedmedicine.diseaseKidney NeoplasmsSurgerySurvival RateTreatment Outcomemedicine.anatomical_structureAdenocarcinomaFemalebusinessFollow-Up StudiesKidney diseaseUrology
researchProduct

Conservative surgery of renal cell carcinoma.

1986

Abstract From 1967 to 1985 conservative surgery (enucleation, n = 49; partial resection, n = 7) was performed for renal tumors in 57 patients (age 31-77, mean 54.8 years). Imperative indications for conservative surgery (n = 29) were chronic renal failure, benign pathology of contralateral kidney, functional or anatomical solitary kidney, and bilateral tumors. Elective conservative surgery (n = 28) was done for small, peripherally located lesions, in cases of uncertain malignancy and in one tumor detected by chance during stone surgery. Tumors removed for imperative indications were 2-11 cm (mean 5.8 cm) in size. In the elective group, tumor size ranged from 1 to 7 cm (mean 3.3 cm). Follow-…

AdultMalemedicine.medical_specialtyUrologySolitary kidneyEnucleationMalignancyBenign pathologyPostoperative ComplicationsRenal cell carcinomaMethodsMedicineHumansCarcinoma Renal CellAgedTumor sizebusiness.industryCancerPartial resectionMiddle Agedmedicine.diseasePrognosisKidney NeoplasmsSurgeryFemalebusinessEuropean urology
researchProduct

Conservative surgery of renal cell tumors in 140 patients: 21 years of experience.

1992

Operative method, course and complications were analyzed retrospectively in 140 patients who underwent a conservative operation for renal tumor between June 1969 and December 1990. In 53 patients (20 women and 33 men, mean age 61.2 years, range 38 to 77 years, with 49 renal cell carcinomas and 4 benign renal tumors) there was an imperative indication for an organ preserving operation because nephrectomy would have made dialysis obligatory. In 87 patients (29 women and 58 men, mean age 53.7 years, range 27 to 74 years, with 72 renal cell carcinomas and 15 benign renal tumors) the tumor was conservatively resected in the presence of a normal contralateral unit (elective indication) and 68 of …

AdultMalemedicine.medical_specialtyUrologymedicine.medical_treatmentEnucleationPostoperative ComplicationsRenal cell carcinomamedicineCarcinomaHumansSurvival rateCarcinoma Renal CellDialysisAgedNeoplasm StagingRetrospective StudiesKidneybusiness.industryMiddle Agedmedicine.diseaseNephrectomyKidney NeoplasmsSurgerySurvival Ratemedicine.anatomical_structureTumor progressionSurgical Procedures OperativeFemaleNeoplasm Recurrence LocalbusinessFollow-Up StudiesThe Journal of urology
researchProduct

NEPHRON SPARING SURGERY FOR CENTRAL RENAL TUMORS: EXPERIENCE WITH 33 CASES

2000

Purpose: Nephron sparing surgery is standard treatment for small, peripherally located renal cell carcinoma. In patients with a solitary kidney, bilateral tumors or impaired renal function nephron sparing surgery provides the only option to nephrectomy and subsequent hemodialysis or transplantation. We retrospectively investigated the value of nephron sparing surgery for centrally located renal cell carcinoma. Materials and Methods: Between 1969 and 1997, 311 renal tumor enucleations were performed at our institution. The tumor was centrally located in 33 cases. The indication for enucleation was elective in 7 cases and imperative in 26, including bilateral tumor in 16 (metachronous in 9 an…

AdultMalemedicine.medical_specialtyUrologymedicine.medical_treatmentmedia_common.quotation_subjectEnucleationNephrectomyRenal cell carcinomamedicineHumansCarcinoma Renal CellAgedRetrospective Studiesmedia_commonKidneybusiness.industryConvalescenceMiddle Agedmedicine.diseaseKidney NeoplasmsNephrectomySurgeryTransplantationmedicine.anatomical_structureFemaleHemodialysisbusinessFollow-Up StudiesKidney diseaseJournal of Urology
researchProduct

Contrast-enhanced second-harmonic sonography in the detection of pseudocapsule in renal cell carcinoma.

2004

“OBJECTIVE. Our purpose was to assess the capacity of contrast-enhanced second-harmonic sonography to detect a pseudocapsule in renal masses compared with conventional gray-scale sonography. SUBJECTS AND METHODS. Thirty-two patients with 40 renal masses suspicious for renal cancer (mean diameter, 3.1 cm) were prospectively studied with contrast-enhanced second-harmonic sonography during IV administration of a second-generation sonographic contrast agent. The sonographic criteria for the presence of a pseudocapsule were a peritumoral hypoanechoic halo on conventional gray-scale imaging and a rim of perilesional enhancement, increasing in the tardive phase of the examination, on contrast-enha…

AdultMalemedicine.medical_specialtymedia_common.quotation_subjectContrast MediaMetastasisRenal cell carcinomamedicineCarcinomaContrast (vision)HumansRadiology Nuclear Medicine and imagingProspective StudiesLung cancerCarcinoma Renal Cellmedia_commonAgedUltrasonographyAged 80 and overbusiness.industryCancerGeneral MedicineMiddle Agedmedicine.diseaseKidney NeoplasmsDynamic contrast-enhanced MRIFemaleRadiologybusinessKidney diseaseAJR. American journal of roentgenology
researchProduct

Transcatheter embolization of a renal artery pseudoaneurysm after open partial nephrectomy.

2011

Twelve days after an open partial nephrectomy, a 31-year-old man was re-admitted urgently for acute lumbar pain. An emergent helical computed tomography scan with intravenous contrast revealed a 3-cm renal artery pseudoaneurysm at the site of the partial nephrectomy, which was responsible for a large perirenal hematoma. Transarterial hyperselective embolization successfully occluded the pseudoaneurysm with less than 1 mL of N-butyl-2-cyanoacrylate, an embolizing agent less costly than coils. The kidney parenchyma was fully preserved.

AdultMalemedicine.medical_specialtymedicine.medical_treatmentContrast MediaNephrectomyPseudoaneurysmLumbarRenal Arterymedicine.arteryMedicineHumanscardiovascular diseasesEmbolizationRenal arteryKidneybusiness.industryAngiographyGeneral MedicineEnbucrilatemedicine.diseaseEmbolization TherapeuticNephrectomySurgeryClear cell renal cell carcinomamedicine.anatomical_structureTreatment Outcomecardiovascular systemPerirenal hematomaSurgeryTissue AdhesivesRadiologybusinessTomography X-Ray ComputedAneurysm FalseAmerican journal of surgery
researchProduct

p53 and Ki-67 expression in renal cell carcinomas of pregnant women and their correlation with prognosis: a pilot study.

2007

In the present study, we reported two cases of renal cell carcinoma (RCC) diagnosed in pregnant women (Pt) that were submitted to radical nephrectomy, in both cases within the fourth month. The patients, after 13 and 3 years, respectively, did not show evidence of recurrent disease. We performed an immunohistochemical study on RCC specimens in comparison to seven age-matched controls (Cl). The panel of antibodies included Ki-67, p53, bcl-2, ER, PgR, PCNA, and IGF-1. We describe a difference in the expression of p53 and Ki-67. Specifically, p53 was highly expressed in RCC of both Pt but scarcely present or absent in Cl; by contrast, Ki-67 was hardly expressed or negative in RCC of both Pt, b…

Adultmedicine.medical_specialtyPathologymedicine.medical_treatmentPilot ProjectsDiseaseGastroenterologyNephrectomyImmunoenzyme Techniquescarcinomas prognosisRenal cell carcinomaPregnancyInternal medicinemedicineBiomarkers TumorHumansCarcinoma Renal CellKEYWORDS: IGF-1 Ki-67 pregnancy p53 protein renal cell carcinoma.Pregnancybiologybusiness.industryObstetrics and Gynecologymedicine.diseasePrognosisNephrectomyKidney NeoplasmsProliferating cell nuclear antigenKi-67 AntigenOncologyKi-67biology.proteinImmunohistochemistryFemalePregnant WomenAntibodyTumor Suppressor Protein p53businessPregnancy Complications Neoplastic
researchProduct

Elective nephron sparing surgery for renal cell carcinoma larger than 4 cm.

2007

Elective nephron sparing surgery is established as an alternative to radical nephrectomy for renal cell carcinoma if tumors are small (4 cm or less, stage T1a). We compared outcomes in patients with renal cell carcinoma 4 cm or less (small) vs more than 4 cm (large) who were treated with nephron sparing surgery.Between 1979 and 2006, 618 patients underwent elective nephron sparing surgery at our institution. Of these patients 474 (76.7%) had renal cell carcinoma, which was 4 cm or less in 372 (78.5%) and more than 4 cm in 102 (21.5%). Followup was 4.7 (range 0.1 to 23.9) years for small and 4.7 (range 0.1 to 24.1) years for large tumors. Cancer specific survival and local recurrence free su…

Adultmedicine.medical_specialtyUrologymedicine.medical_treatmentUrologyNephrectomyRenal cell carcinomaparasitic diseasesmedicineCarcinomaHumansStage (cooking)Survival rateCarcinoma Renal CellAgedRetrospective StudiesAged 80 and overKidneybusiness.industryNephronsMiddle Agedmedicine.diseaseNephrectomyKidney NeoplasmsSurgeryLog-rank testmedicine.anatomical_structureNephron sparing surgerybusinessThe Journal of urology
researchProduct

The changes of lipid metabolism in advanced renal cell carcinoma patients treated with everolimus: a new pharmacodynamic marker?

2015

Background: Everolimus is a mammalian target of rapamycin (mTOR) inhibitor approved for the treatment of metastatic renal cell carcinoma (mRCC). We aimed to assess the association between the baseline values and treatmentrelated modifications of total serum cholesterol (C), triglycerides (T), body mass index (BMI), fasting blood glucose level (FBG) and blood pressure (BP) levels and the outcome of patients treated with everolimus for mRCC. Methods: 177 patients were included in this retrospective analysis. Time to progression (TTP), clinical benefit (CB) and overall survival (OS) were evaluated. Results: Basal BMI was significantly higher in patients who experienced a CB (p=0,0145). C, T an…

Blood Glucoselcsh:MedicineBlood Pressureurologic and male genital diseasesTriglycerideBody Mass IndexAntineoplastic Agentchemistry.chemical_compoundRetrospective StudieRenal cell carcinomalcsh:ScienceMultidisciplinaryKidney NeoplasmKidney NeoplasmsSurvival RateEverolimuCholesterolDisease ProgressionHumanmedicine.drugResearch ArticleAdultmedicine.medical_specialtyAdolescentUrologyBlood sugarAntineoplastic AgentsYoung AdultInternal medicinemedicineCarcinomaHumansEverolimusCarcinoma Renal CellTriglyceridesNeoplasm StagingRetrospective StudiesBiochemistry Genetics and Molecular Biology (all)EverolimusCholesterolbusiness.industrylcsh:RCarcinomaRenal CellAdolescent; Adult; Antineoplastic Agents; Biomarkers; Blood Glucose; Blood Pressure; Body Mass Index; Carcinoma Renal Cell; Cholesterol; Disease Progression; Everolimus; Humans; Kidney Neoplasms; Lipid Metabolism; Neoplasm Staging; Retrospective Studies; Survival Rate; Triglycerides; Young Adult; Biochemistry Genetics and Molecular Biology (all); Agricultural and Biological Sciences (all)Lipid metabolismBiomarkermedicine.diseaseLipid Metabolismrenal; carcinomaBlood pressureEndocrinologyAgricultural and Biological Sciences (all)chemistryPharmacodynamicslcsh:QbusinessBiomarkersPloS one
researchProduct